ATB Capital Has Lowered Expectations for Organigram (TSE:OGI) Stock Price

ATB Capital Has Lowered Expectations for Organigram (TSE:OGI) Stock Price

ATB Capital cut their target price on shares of Organigram from C$5.25 to C$3.50 in a research note on Tuesday.

Organigram Reports Revenue Growth in Fiscal 2024, But Net Losses Continue

Organigram Holdings Inc. (TSX: OGI) has reported its financial results for fiscal year 2024, ending September 30, 2024, posting annual net revenue of $159.8 million, up 6% compared to $150.4 million in fiscal 2023. This modest growth stemmed primarily from increased recreational cannabis sales and expanding international revenues. While the increase is noteworthy in a challenging market, it pales in comparison to the 22% year-over-year increase …

Organigram Q4 Revenue Surges 22%, Secures $124.6M BAT Investment as Canada's New Cannabis Leader

Organigram reports strong Q4 with revenue jumping 22% YoY to $44.7M, achieves market leadership in Canada post-Motif acquisition, and strengthens position with major BAT funding.